The Annual International Symposium on Myeloproliferative Neoplasms

* The program is subject to change without notice.

* Time listed in Taiwan Standard Time.

09:30 – 09:50Registration

09:50 – 09:55

Opening RemarksDr. Wen-Chien Chou
MPN: What's New?

09:55 – 10:20

MPN Updates and the Evolution of the Disease

Dr. Ruben Mesa

Dr. Norio Komatsu

Dr. Dong-Tsamn Lin

10:20 – 10:45Clinical Relevance of Mutation Allele Burden in MPN

Dr. Hsin-An Hou

10:45 – 11:10A Paradigm Shift in The Diagnosis and Treatment of MPNs, Sooner Better than Later?

Dr. Hans K Hasselbalch

11:10 – 11:25Coffee Break
Interferon Treatment in PV: Revolution
11:25 – 11:50Six-year Results of the PROUD/CONTI-PV StudyDr. Jean-Jacques Kiladjian

Dr. Kazuya Shimoda

Dr. Sung-Yong Kim

11:50 – 12:15Efficacy and Safety of Ropeginterferon Alfa-2b Treatment in Japanese Patients with PVDr. Keita Kirito
12:15 – 12:40Molecular Response of Ropeginterferon Alfa-2b in Korea Patients with PVDr. Sung-Eun Lee
12:40 – 13:40Lunch
Clinical Diagnosis and Characteristics of MPN
13:40 – 14:05Polycythemia Vera 2023. Can We Improve Outcomes?

Dr. Josef T. Prchal

Dr. Lee-Yung Shih

Dr. Hein Than

14:05 – 14:30Clinical Characteristics of Japanese Patients with PV/ET

Dr. Katsuto Takenaka

14:30 – 14:55Clinical Phenotype and Prognosis of JAK2 and CALR Mutation in Asian Patients with ET

Dr. Chin-Hin Ng

14:55 – 15:20Role of Genetic Variants in Predicting Efficacy and/or Adverse Events of Ropeginterferon Alfa-2b in MPN Patients

Dr. Chih-Cheng Chen

15:20 – 15:35Coffee Break
Unmet Needs and Advances in MPN
15:35 – 16:00Intervention in Prefibrotic and Early Overt Myelofibrosis

Dr. Abdulraheem Yacoub

Dr. Chul-Won Choi

16:00 – 16:25Ropeginterferon Alfa-2b in Early Myelofibrosis

Dr. Harry Gill

16:25 – 16:45Novel Pegylated Interferon for the Treatment of Chronic Viral Hepatitis

Dr. Pei-Jer Chen

16:45 – 17:10Panel Discussion

Dr. Ruben Mesa

Dr. Josef Prchal

Dr. Hans K Hasselbalch

Dr. Chih-Cheng Chen

Dr. Hsin-An Hou

Dr. Harry Gill

Dr. Jean-Jacques Kiladjian

Dr. Hwei-Fang Tien

17:10 – 17:15Closing RemarksDr. Wen-Chien Chou